Skip to main content
Top
Published in: Clinical Rheumatology 9/2013

01-09-2013 | Brief Report

The uveitis and its relationship with disease activity and quality of life in Moroccan children with juvenile idiopathic arthritis

Authors: M. Ezzahri, B. Amine, S. Rostom, Y. Rifay, D. Badri, N. Mawani, S. Gueddari, S. Shyen, M. Wabi, F. Moussa, R. Abouqal, B. Chkirate, N. Hajjaj-Hassouni

Published in: Clinical Rheumatology | Issue 9/2013

Login to get access

Abstract

The aim of our study is to investigate ocular involvement in juvenile idiopathic arthritis (JIA) and its relationship with disease activity and quality of life in Moroccan patients who suffer from JIA. This is a cross-sectional study conducted between January and June 2012 which includes patients with juvenile idiopathic arthritis (n = 30). All patients have undergone clinical and paraclinical assessment of JIA and a complete eye examination. Functional impairment is assessed by the Childhood Health Assessment Questionnaire while visual function is studied by the Effect of Youngsters’ Eyesight in Quality of Life instrument (EYE-Q). Quality of life is assessed using the Pediatric Quality of Life Inventory Version 4.0 (PedsQL 4.0). Four patients (13.33 %) have uveitis with a confidence interval between 3.4 and 30.7. Involvement is bilateral in three children (75 %). One patient (25 %) has elevated intraocular pressure with loss of the right eye due to glaucoma. There is a strong but not significant relationship between uveitis and the number of awakenings (r = 0.71, p = 0.69) and morning stiffness (r = 3.05, p = 0, 21). This relationship is moderate with erythrocyte sedimentation rate (r = 0.48, p = 0.78) and C-reactive protein (r = 0.25, p = 0.88). A strong but not significant association is found between the overall quality of life assessed by the PedsQL 4.0 and visual function assessed by EYE-Q in the uveitis group (r = −0.64, p = 0.55). This study suggests that uveitis associated with JIA can present serious complications and could have a direct relationship with the activity of the JIA as well as with the quality of life of the patient.
Literature
1.
go back to reference Kaisu K, Anneli S, Anni K, Kimmo A (2003) Recent advances in uveitis of juvenile idiopathic arthritis. Surv Ophthalmol 48(5):489–502CrossRef Kaisu K, Anneli S, Anni K, Kimmo A (2003) Recent advances in uveitis of juvenile idiopathic arthritis. Surv Ophthalmol 48(5):489–502CrossRef
2.
go back to reference Saurenmann RK, Levin AV, Feldman BM et al (2007) Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term follow-up study. Arthritis Rheum 56:647–657PubMedCrossRef Saurenmann RK, Levin AV, Feldman BM et al (2007) Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term follow-up study. Arthritis Rheum 56:647–657PubMedCrossRef
3.
go back to reference Sabri K, Saurenmann RK, Silverman ED, Levin AV (2008) Course, complications, and outcome of juvenile arthritis-related uveitis. J AAPOS 12:539–545PubMedCrossRef Sabri K, Saurenmann RK, Silverman ED, Levin AV (2008) Course, complications, and outcome of juvenile arthritis-related uveitis. J AAPOS 12:539–545PubMedCrossRef
4.
go back to reference Thorne JE, Woreta F, Kedhar SR et al (2007) Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 143:840–846PubMedCrossRef Thorne JE, Woreta F, Kedhar SR et al (2007) Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 143:840–846PubMedCrossRef
5.
go back to reference Oren B, Sehgal A, Simon JW, Lee J, Blocker RJ, Biglan AW, Zobal-Ratner J (2001) The prevalence of uveitis in juvenile rheumatoid arthritis. J AAPOS 5(1):2–4PubMedCrossRef Oren B, Sehgal A, Simon JW, Lee J, Blocker RJ, Biglan AW, Zobal-Ratner J (2001) The prevalence of uveitis in juvenile rheumatoid arthritis. J AAPOS 5(1):2–4PubMedCrossRef
6.
go back to reference Amine B, Rostom S, Benbouazza K, Abouqal R, Hajjaj-Hassouni N (2009) Health related quality of life survey about children and adolescents with juvenile idiopathic arthritis. Rheumatol Int 29:275–279PubMedCrossRef Amine B, Rostom S, Benbouazza K, Abouqal R, Hajjaj-Hassouni N (2009) Health related quality of life survey about children and adolescents with juvenile idiopathic arthritis. Rheumatol Int 29:275–279PubMedCrossRef
7.
go back to reference Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed
8.
go back to reference Rostom S, Amine B, Bensabbah R, Chkirat B, Hajjaj-Hassouni RAN (2010) Psychometric properties evaluation of the childhood health assessment questionnaire (CHAQ) in Moroccan juvenile idiopathic arthritis. Rheumatol Int 30:879–885PubMedCrossRef Rostom S, Amine B, Bensabbah R, Chkirat B, Hajjaj-Hassouni RAN (2010) Psychometric properties evaluation of the childhood health assessment questionnaire (CHAQ) in Moroccan juvenile idiopathic arthritis. Rheumatol Int 30:879–885PubMedCrossRef
9.
go back to reference Angeles-Han ST, Griffin KW, Lehman TJ, Rutledge JR, Lyman S, Nguyen JT, Harrison MJ (2010) The importance of visual function in the quality of life of children with uveitis. J AAPOS 14(2):163–168PubMedCrossRef Angeles-Han ST, Griffin KW, Lehman TJ, Rutledge JR, Lyman S, Nguyen JT, Harrison MJ (2010) The importance of visual function in the quality of life of children with uveitis. J AAPOS 14(2):163–168PubMedCrossRef
10.
go back to reference WHOQOL Group (1993) The development of the World Health Organization quality of life assessment instrument (the WHOQOL). Qual Life Res 2(2):153–159CrossRef WHOQOL Group (1993) The development of the World Health Organization quality of life assessment instrument (the WHOQOL). Qual Life Res 2(2):153–159CrossRef
11.
go back to reference Boone MI, Moore TL, Cruz OA (1998) Screening for uveitis in juvenile rheumatoid arthritis. J Pediatr Ophthalmol Strabismus 34:41–43 Boone MI, Moore TL, Cruz OA (1998) Screening for uveitis in juvenile rheumatoid arthritis. J Pediatr Ophthalmol Strabismus 34:41–43
12.
go back to reference Sherry DD, Mellins ED, Wedgewood RJ (1991) Decreasing severity of chronic uveitis in children with pauciarticular arthritis. Am J Dis Child 145:1026–1028PubMed Sherry DD, Mellins ED, Wedgewood RJ (1991) Decreasing severity of chronic uveitis in children with pauciarticular arthritis. Am J Dis Child 145:1026–1028PubMed
13.
go back to reference Kotaniemi K, Kautianen H, Karma A et al (2001) Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmol 108:2071–2075CrossRef Kotaniemi K, Kautianen H, Karma A et al (2001) Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmol 108:2071–2075CrossRef
14.
go back to reference Angeles-Han S, Yeh S (2012) Prevention and management of cataracts in children with juvenile idiopathic arthritis–associated uveitis. Curr Rheumatol 14:142–149CrossRef Angeles-Han S, Yeh S (2012) Prevention and management of cataracts in children with juvenile idiopathic arthritis–associated uveitis. Curr Rheumatol 14:142–149CrossRef
15.
go back to reference Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, Leirisalo-Repo M (2005) Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis 64:871–874PubMedCrossRef Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, Leirisalo-Repo M (2005) Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis 64:871–874PubMedCrossRef
16.
go back to reference Paroli MP, Speranza S, Marino M et al (2003) Prognosis of juvenile rheumatoid arthritis-associated uveitis. Eur J Ophthalmol 13:616–621PubMed Paroli MP, Speranza S, Marino M et al (2003) Prognosis of juvenile rheumatoid arthritis-associated uveitis. Eur J Ophthalmol 13:616–621PubMed
17.
go back to reference Foster CS, Havrlikova K, Baltatzis S et al (2000) Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmol Scand 78:576–579PubMedCrossRef Foster CS, Havrlikova K, Baltatzis S et al (2000) Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmol Scand 78:576–579PubMedCrossRef
18.
go back to reference Rosenberg KD, Feuer WJ, Davis JL (2004) Ocular complications of pediatric uveitis. Ophthalmol 111:2299–2306CrossRef Rosenberg KD, Feuer WJ, Davis JL (2004) Ocular complications of pediatric uveitis. Ophthalmol 111:2299–2306CrossRef
19.
go back to reference Kotaniemi K, Kotaniemi A, Savolainen A (2002) Uveitis as a marker of active arthritis in 372 patients with juvenile idiopathic seronegative oligoarthritis or polyarthritis. Clin Exp Rheumatol 20:109–112PubMed Kotaniemi K, Kotaniemi A, Savolainen A (2002) Uveitis as a marker of active arthritis in 372 patients with juvenile idiopathic seronegative oligoarthritis or polyarthritis. Clin Exp Rheumatol 20:109–112PubMed
Metadata
Title
The uveitis and its relationship with disease activity and quality of life in Moroccan children with juvenile idiopathic arthritis
Authors
M. Ezzahri
B. Amine
S. Rostom
Y. Rifay
D. Badri
N. Mawani
S. Gueddari
S. Shyen
M. Wabi
F. Moussa
R. Abouqal
B. Chkirate
N. Hajjaj-Hassouni
Publication date
01-09-2013
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2262-y

Other articles of this Issue 9/2013

Clinical Rheumatology 9/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine